RXRX
Recursion Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $2.54B | Price | $5.52 |
| Volume | 43.30M | Change | -2.30% |
| P/E Ratio | -5.5 | Open | $5.70 |
| Revenue | $58.8M | Prev Close | $5.65 |
| Net Income | $-463.7M | 52W Range | $3.79 - $12.36 |
| Div Yield | N/A | Target | $6.47 |
| Overall | 50 | Value | 60 |
| Quality | -- | Technical | 41 |
No chart data available
Stock Overview
Updated DailyRecursion Pharmaceuticals Inc. (RXRX) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $5.52 with a market capitalization of $2.54 billion. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows RXRX with a volume of 43.30 million shares. The stock opened up 0.88% from yesterday's close of $5.65. Current analyst estimates project earnings of $-1.53 per share for this year, with next year targeting $-1.16.
RXRX demonstrates weak technical indicators based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for RXRX include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 17.2%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 01:35 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RXRX | $5.52 | -2.3% | 43.30M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Recursion Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW